April 13, 2023 07:15 AM EDT
FDA+

Ghana ap­proves Ox­ford Uni­ver­si­ty's malar­ia vac­cine for chil­dren

Katherine Lewin

News Reporter

The R21/Ma­trix-M malar­ia vac­cine has scored its first reg­u­la­to­ry clear­ance world­wide with an ap­proval by FDA Ghana, Ox­ford Uni­ver­si­ty an­nounced to­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

A service from the Financial Times